360 Results

People

  1. Lacouture
    Lacouture
  2. Panageas
    Panageas
  3. Wolchok
    Wolchok
  4. Motzer
    Motzer
  5. Postow
    Postow
  6. Houghton
    Houghton
  7. Zelenetz
    Zelenetz
  8. Balagula
    Balagula
  9. Livingston
    Livingston
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (267)
  2. Solid Tumor Oncology Division (171)
  3. Survivorship Research (88)
  4. Division of Subspecialty Medicine (79)
  5. Hematologic Malignancies, Division of (71)
  6. Dermatology (65)
  7. Dermatology Service (63)
  8. GSK Faculty (53)
  9. Melanoma Disease Management Team (47)
  10. Melanoma and Immunotherapeutics Service (47)
  1. "pruritus"
Formats
  1. Journal Article (336)
  2. Review (15)
  3. Research Letter (3)
  4. Editorial (2)
  5. Miscellaneous (2)
  6. Conference Paper (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (267)
  2. Solid Tumor Oncology Division (171)
  3. Survivorship Research (88)
  4. Division of Subspecialty Medicine (79)
  5. Hematologic Malignancies, Division of (71)
  6. Dermatology (65)

More Groups

People
  1. Mario Lacouture (44)
  2. Jedd Wolchok (29)
  3. Katherine Panageas (16)
  4. Paul Chapman (16)
  5. Robert Motzer (14)
  6. Michael Postow (11)

More People

Years
  1. 2025 (11)
  2. 2024 (38)
  3. 2023 (28)
  4. 2022 (12)
  5. 2021 (16)
  6. 2020 (24)

More Years

Publications
  1. Lancet Oncology (30)
  2. Clinical Cancer Research (17)
  3. Journal of Clinical Oncology (17)
  4. Cancer (11)
  5. Journal of the American Academy of Dermatology (11)
  6. Annals of Oncology (9)

More Publications

Publishers
  1. Elsevier Inc. (46)
  2. Elsevier Science, Inc. (39)
  3. Springer (26)
  4. Nature Publishing Group (22)
  5. American Association for Cancer Research (20)
  6. American Society of Clinical Oncology (18)

More Publishers

Results (360)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer
    Review

    Brower, B.; McCoy, A.; Ahmad, H.; Eitman, C.; Bowman, I. A.; Rembisz, J.; Milowsky, M. I.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Outcome of patients with perihilar cholangiocarcinoma and previous biliary instrumentation: An observational study
    Journal Article

    Brown, K. T.; Chou, J. F.; Suchy, H. B.; Getrajdman, G. I.; Gonen, M.; Covey, A. M.; Brody, L. A.; Schattner, M. A.; D’Angelica, M. I.; Kingham, T. P.; more...
    BMC Gastroenterology (2024)

    Fulltext@MSK | Save
  • Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the phase II VISION study
    Journal Article

    Morise, M.; Kato, T.; Matsumoto, S.; Inoue, T.; Sakamoto, T.; Tokito, T.; Atagi, S.; Kozuki, T.; Takeoka, H.; Chikamori, K.; more...
    Cancer Science (2024)

    Fulltext@MSK | Save
  • A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: Phase 1 trial interim results
    Journal Article

    Rappaport, A. R.; Kyi, C.; Lane, M.; Hart, M. G.; Johnson, M. L.; Henick, B. S.; Liao, C. Y.; Mahipal, A.; Shergill, A.; Spira, A. I.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Defining D-irAEs: Consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy
    Journal Article

    Chen, S. T.; Semenov, Y. R.; Alloo, A.; Bach, D. Q.; Betof Warner, A.; Bougrine, A.; Burton, L.; Cappelli, L. C.; Castells, M.; Cohen, J.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
    Journal Article

    Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • BRAF — A tumour-agnostic drug target with lineage-specific dependencies
    Review

    Hanrahan, A. J.; Chen, Z.; Rosen, N.; Solit, D. B.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors
    Journal Article

    Bang, A. S.; Fay, C. J.; LeBoeuf, N. R.; Etaee, F.; Leventhal, J. S.; Sibaud, V.; Arbesman, J.; Wang, J. Y.; Kwong, B. Y.
    Breast Cancer Research and Treatment (2024)

    Fulltext@MSK | Save
  • Treatment for first cytomegalovirus infection post–hematopoietic cell transplant in the AURORA trial: A multicenter, double-blind, randomized, phase 3 trial comparing maribavir with valganciclovir
    Journal Article

    Papanicolaou, G. A.; Avery, R. K.; Cordonnier, C.; Duarte, R. F.; Haider, S.; Maertens, J.; Peggs, K. S.; Solano, C.; Young, J. A. H.; Fournier, M.; more...
    Clinical Infectious Diseases (2024)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): An interim analysis of the multicentre, double-blind, randomised phase 3 study
    Journal Article

    Shitara, K.; Rha, S. Y.; Wyrwicz, L. S.; Oshima, T.; Karaseva, N.; Osipov, M.; Yasui, H.; Yabusaki, H.; Afanasyev, S.; Park, Y. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save